Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome

NCT00436033 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.

NCT NCT00436033
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00436033 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A European Phase III, Multicentre, Double-blind, Randomised, Placebo-controlled Monotherapy Study of Milnacipran for the Treatment of Fibromyalgia Syndrome
Lead sponsor
Pierre Fabre Medicament
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2006
Completion date
September 30, 2007
Enrollment
1,429 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia syndrome